Literature DB >> 16951429

Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies.

G H Woldringh1, M H A Frunt, J A M Kremer, M E A Spaanderman.   

Abstract

BACKGROUND: Pre-eclampsia affects 2-10% of all pregnancies and is a major cause of maternal and fetal morbidity and mortality. As compared with the general population, IVF pregnancies are associated with a 2.7-fold risk of pre-eclampsia. An advanced age and associated subfertility in the IVF group reflects a general decrease in ovarian reserve, which itself has been linked to cardiovascular disease. We tested the hypothesis that decreased ovarian reserve is associated with pre-eclampsia as a vascular complication in IVF/ICSI pregnancies.
METHODS: In this retrospective case-control study, 41 cases with a history of pre-eclampsia were compared to 82 matched controls without hypertension or (pre)eclampsia. All pregnancies were established after IVF or ICSI. Several indicators of ovarian reserve such as variables related to basal ovarian function and response to hyperstimulation were compared in both the groups by multivariate analysis. The condition of the neonates was evaluated as well.
RESULTS: A higher amount of total administered FSH and FSH per day, together with a lower number of obtained oocytes during IVF treatment, were associated with an increased risk to pre-eclampsia in a subsequent pregnancy. The administered FSH per follicle and per obtained oocyte showed even stronger relationships, the latter having the best predictive value. Neonatal outcome was comparable between the groups.
CONCLUSION: Diminished responsiveness of the ovaries to FSH stimulation in an IVF cycle, reflecting decreased ovarian reserve, is associated with an increased risk of developing pre-eclampsia in a subsequent pregnancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951429     DOI: 10.1093/humrep/del155

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Enhanced hypothalamic-pituitary sensitivity to estrogen in premenopausal women with diminished ovarian reserve compared with older perimenopausal controls.

Authors:  Katie Zhang; Gohar Zeitlian; Goli Adel; Nanette F Santoro; Lubna Pal
Journal:  Menopause       Date:  2011-08       Impact factor: 2.953

2.  Preconception ovarian reserve and placenta-mediated pregnancy complications among infertile women.

Authors:  Wendy Vitek; Jinhee Oh; Omar Mbowe; Sally W Thurston; Mindy S Christianson; Aaron K Styer; Alex J Polotsky; Michael P Diamond; Marcelle I Cedars
Journal:  Pregnancy Hypertens       Date:  2022-02-02       Impact factor: 2.899

3.  Obstetric and perinatal outcomes in IVF versus ICSI-conceived pregnancies at a tertiary care center--a pilot study.

Authors:  Kazem Nouri; Johannes Ott; Lucia Stoegbauer; Detlef Pietrowski; Sophie Frantal; Katharina Walch
Journal:  Reprod Biol Endocrinol       Date:  2013-08-31       Impact factor: 5.211

4.  What are the Predictive Factors for Preeclampsia in Oocyte Recipients?

Authors:  Céline Pimentel; Duros Solene; Jaffre Frédérique; Bouzille Guillaume; Leveque Jean; Le Lous Maëla
Journal:  J Hum Reprod Sci       Date:  2019-12-17

5.  A comparison of the efficacy and safety of traditional Chinese medicine in preconditioning patients with diminished ovarian reserve that would undergo In Vitro fertilization: A network meta-analysis protocol.

Authors:  Xiuyun Qin; Yongping Gong; Feng Yu; Jiangquan Song; Shuangqian Dong; Ruoqian Zhang; Jianwei Zhang
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

Review 6.  Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis.

Authors:  Anna Blázquez; Désirée García; Amelia Rodríguez; Rita Vassena; Francesc Figueras; Valérie Vernaeve
Journal:  J Assist Reprod Genet       Date:  2016-03-23       Impact factor: 3.357

7.  Effects of Bushen Huoxue method for female with decreased ovarian reserve: A protocol for systematic review and meta-analysis.

Authors:  Zhuoting Xie; Yin Li; Zehua Chen; Qiuyu Cao; Chunren Zhang; Yang Fei; Kunyin Li; Yongge Guan
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.